In 1940, British Prime Minister Winston Churchill famously said, in relation to the Battle of Dunkirk, “Wars are not won by ...
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company (“ImmunityBio”), today announced the successful completion of its acquisition of the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The Los Angeles-based company is far different from Athenex ...
Over 400,000 square foot, state-of-the-art, finish-fill and lyophilization facility enables one billion doses of RNA and adjuvant vaccine production Newly constructed Current Good Manufacturing ...
The 409,000-square-foot Athenex facility is located off Route 5 in the town of Dunkirk. ImmunityBio, Inc., a clinical-stage immunotherapy company, announced Tuesday it has completed acquisition of the ...
As it continues construction, ImmunityBio noted in a quarterly regulatory filing that it believes governmental funding will assist in funding a portion of the further build-out in Dunkirk. As of March ...
DUNKIRK, N.Y. — ImmunityBio has filed a WARN notice with the New York state Department of Labor for two layoffs at its plant in Dunkirk. According to the notice, the California-based biopharmaceutical ...
As it continues construction, ImmunityBio noted in a quarterly regulatory filing that it believes governmental funding will assist in funding a portion of the further build-out in Dunkirk. As of March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results